Tumor microvessel density and prognosis in node-negative breast cancer

International Journal of Cancer

Volumn 89, Issue 1, 2000, Pages 74-80

  Medri, Laura ^a   Nanni, Oriana ^b   Volpi, Annalisa ^a   Scarpi, Emanuela ^b   Dubini, Alessandra ^a   Riccobon, Angela ^a   Becciolini, Aldo ^c   Bianchi, Simonetta ^c   Amadori, Dino ^a  

^a MORGAGNI PIERANTONI HOSPITAL   (Italy)

^b ISTITUTO ONCOLOGICO ROMAGNOLO   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXIDASE; STEROID RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER SURVIVAL; CELL PROLIFERATION; CORRELATION FUNCTION; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; TUMOR VASCULARIZATION; TUMOR VOLUME;

BREAST NEOPLASMS; CELL DIVISION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MICROCIRCULATION; MULTIVARIATE ANALYSIS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REPRODUCIBILITY OF RESULTS; SURVIVAL ANALYSIS;

EID: 0034688124     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000120)89:1<74::AID-IJC12>3.0.CO;2-L     Document Type: Article

References (22)

1. AMERICAN SOCIETY OF CLINICAL ONCOLOGY, Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. J. clin. Oncol., 14, 2843-2877 (1996).
2. ARANDA, F.I. and LAFORGA, J.B., Microvessel quantitation in breast ductal invasive carcinoma. Correlation with proliferative activity, hormonal receptors and lymph-node metastases. Path. Res. Pract., 192, 124-129 (1996).
3. AXELSSON, K., LJUNG, B.M.E., MOORE II, D.H., THOR, A.D., CHEW, K.L., EDGERTON, S.M., SMITH, H.S. and MAYALL, B.H., Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J. nat. Cancer Inst., 87, 997-1008 (1995).
4. BOSARI, S., LEE, A.K.C., DELELLIS, R.A., WILEY, B.D., HEATLEY, G.J. and SILVERMAN, M.L., Microvessel quantitation and prognosis in invasive breast carcinoma. Hum. Pathol., 23, 755-761 (1992).
5. COSTELLO, P., MCCANN, A., CARNEY, D.N. and DERVAN, P.A., Prognostic significance of microvessel density in lymph-node-negative breast carcinoma. Hum. Pathol., 26, 1181-1184 (1995).
6. FOLKMAN, J., How is blood vessel growth regulated in normal and neo-plastic tissue? (G.H.A. Clowes Memorial Award Lecture). Cancer Res., 46, 467-473 (1986).
7. FOX, S.B., LEEK, R.D., SMITH, K., HOLLYER, J., GREENALL, M. and HARRIS, A.L., Tumor angiogenesis in node-negative breast carcinomas-relationship with epidermal-growth-factor receptor, estrogen receptor, and survival. Breast Cancer Res. Treat., 29, 109-116 (1994).
8. GASPARINI, G. and HARRIS, A.L., Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J. clin. Oncol., 13, 765-782 (1995).
9. GASPARINI, G., WEIDNER, N., BEVILACQUA, P., MALUTA, S., DALLA PALMA, P., CAFFO, O., BARBARESCHI, M., BORACCHI, P., MARUBINI, E. and POZZA, F., Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic-vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J. clin. Oncol., 12, 454-466 (1994).
10. HALL, N.R., FISH, D.E., HUNT, N., GOLDIN, R.D., GUILLOU, P.J. and MONSON, J.R., Is the relationship between angiogenesis and metastasis in breast cancer real? Surg. Oncol., 1, 223-229 (1992).
11. LAWLESS, J.S., Statistical models and methods for life-time data. Wiley, New York (1982).
12. LINDMARK, G., GERDIN, B., SUNDBERG, C., PAHLMAN, L., BERGSTROM, R. and GLIMELIUS, B., Prognostic significance of the microvascular count in colorectal cancer J. clin. Oncol., 14, 461-466 (1996).
13. MORPHOPOULOS, G., PEARSON, M., RYDER, W.D.J., HOWELL, A. and HARRIS, M., Tumour angiogenesis as a prognostic marker in infiltrating lobular carcinoma of the breast. J. Pathol., 180, 44-49 (1996).
14. OBERMAIR, A., KURZ, C., CZERWENKA, K., THOMA, M., KAIDER, A., WAGNER, T., GITSCH, G. and SEVELDA, P., Microvessel density and vessel invasion in lymph-node-negative breast cancer: effect on recurrence-free survival. Int. J. Cancer. 62, 126-131 (1995).
15. PIFFANELLI, A., PELIZZOLA, D., GIOVANNINI, G., CATOZZI, L., FAGGIOLI, L. and GIGANTI, M., Characterization of laboratory working standards for quality control of immunometric and radiometric estrogen-receptor assays. Clinical evaluation of breast-cancer biopsies. Tumori, 75, 550-556 (1989).
16. RAE, G., On measuring agreement among several judges on the presence-absence of a trait. Educ. Psychol. Mean., 44, 247-253 (1984).
17. 3H-thymidine labelling index in breast cancer. Cell Prolif., 21, 437-445 (1991).
18. 3H-thymidine labelling index. Int. J. Cancer, 74, 122-127 (1997).
19. TOI, M., KASHITANI, J. and TOMINAGA, T., Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int. J. Cancer, 55, 371-374 (1993).
20. VAN HOEF, M.E.H.M., KNOX, W.F., DHESI, S.S., HOWELL, A. and SCHOR, A.M., Assessment of tumour vascularity as a prognostic factor in lymph-node-negative invasive breast cancer. Europ. J. Cancer, 29A, 1141-1145 (1993).
21. VARTANIAN, R.K. and WEIDNER, N., Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor-cell proliferation in breast carcinoma. Amer. J. Pathol., 144, 1188-1193 (1994).
22. WEIDNER, N., FOLKMAN, J., POZZA, F., BEVILACQUA, P., ALLRED, E.N., MOORE, D.H., MELI, S. and GASPARINI, G., Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J. nat. Cancer Inst., 84, 1875-1887 (1992).